Becton Dickinson Total Current Assets 2010-2024 | BDX
Becton Dickinson total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
- Becton Dickinson total current assets for the quarter ending June 30, 2024 were $12.207B, a 42.14% increase year-over-year.
- Becton Dickinson total current assets for 2023 were $8.676B, a 6.57% increase from 2022.
- Becton Dickinson total current assets for 2022 were $8.141B, a 7.89% decline from 2021.
- Becton Dickinson total current assets for 2021 were $8.838B, a 1.46% decline from 2020.
Becton Dickinson Annual Total Current Assets
(Millions of US $) |
| 2023 |
$8,676 |
| 2022 |
$8,141 |
| 2021 |
$8,838 |
| 2020 |
$8,969 |
| 2019 |
$6,664 |
| 2018 |
$7,411 |
| 2017 |
$18,633 |
| 2016 |
$6,367 |
| 2015 |
$5,659 |
| 2014 |
$6,131 |
| 2013 |
$5,873 |
| 2012 |
$5,322 |
| 2011 |
$4,668 |
| 2010 |
$4,505 |
| 2009 |
$4,647 |
Becton Dickinson Quarterly Total Current Assets
(Millions of US $) |
| 2024-06-30 |
$12,207 |
| 2024-03-31 |
$10,340 |
| 2023-12-31 |
$8,156 |
| 2023-09-30 |
$8,676 |
| 2023-06-30 |
$8,588 |
| 2023-03-31 |
$9,587 |
| 2022-12-31 |
$8,175 |
| 2022-09-30 |
$8,141 |
| 2022-06-30 |
$9,547 |
| 2022-03-31 |
$10,152 |
| 2021-12-31 |
$8,307 |
| 2021-09-30 |
$8,838 |
| 2021-06-30 |
$9,538 |
| 2021-03-31 |
$10,000 |
| 2020-12-31 |
$9,537 |
| 2020-09-30 |
$8,969 |
| 2020-06-30 |
$8,827 |
| 2020-03-31 |
$8,555 |
| 2019-12-31 |
$6,438 |
| 2019-09-30 |
$6,664 |
| 2019-06-30 |
$6,781 |
| 2019-03-31 |
$6,844 |
| 2018-12-31 |
$6,941 |
| 2018-09-30 |
$7,411 |
| 2018-06-30 |
$7,525 |
| 2018-03-31 |
$7,512 |
| 2017-12-31 |
$7,542 |
| 2017-09-30 |
$18,633 |
| 2017-06-30 |
$18,212 |
| 2017-03-31 |
$4,891 |
| 2016-12-31 |
$5,187 |
| 2016-09-30 |
$6,367 |
| 2016-06-30 |
$6,534 |
| 2016-03-31 |
$6,612 |
| 2015-12-31 |
$5,641 |
| 2015-09-30 |
$5,659 |
| 2015-06-30 |
$6,303 |
| 2015-03-31 |
$6,996 |
| 2014-12-31 |
$12,111 |
| 2014-09-30 |
$6,131 |
| 2014-06-30 |
$6,045 |
| 2014-03-31 |
$5,946 |
| 2013-12-31 |
$5,743 |
| 2013-09-30 |
$5,873 |
| 2013-06-30 |
$5,435 |
| 2013-03-31 |
$5,500 |
| 2012-12-31 |
$5,477 |
| 2012-09-30 |
$5,322 |
| 2012-06-30 |
$5,285 |
| 2012-03-31 |
$5,301 |
| 2011-12-31 |
$5,694 |
| 2011-09-30 |
$4,668 |
| 2011-06-30 |
$5,073 |
| 2011-03-31 |
$4,857 |
| 2010-12-31 |
$4,951 |
| 2010-09-30 |
$4,505 |
| 2010-06-30 |
$4,123 |
| 2010-03-31 |
$3,939 |
| 2009-12-31 |
$4,057 |
| 2009-09-30 |
$4,647 |
| 2009-06-30 |
$4,492 |
| 2009-03-31 |
$3,408 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$67.812B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
